Skip to main content
Premium Trial:

Request an Annual Quote

NIH to License Odyssey Thera for Molecular Libraries Roadmap Initiative

NEW YORK, Aug. 17 (GenomeWeb News) - Odyssey Thera will license its protein-fragment complementation assays to the National Institutes of Health to aid in the federal body's Molecular Libraries Roadmap Initiative, Odyssey said today.

The NIH will use the assays for screening small molecules with relevance to pharmaceutical discovery. According to the NIH, research using the technology will be conducted at the NIH's ChemicalGenomicsCenter.

Financial details were not disclosed.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.